Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

clinical trial
rdfs:label "Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients"@en
schema:description
"clinical trial"@en
schema:dateModified "2026-03-31T21:41:53+00:00"^^xsd:dateTime
schema:version 2476809372
wikibase:identifiers 1
wikibase:sitelinks 0
wikibase:statements 15
p:P1132 wd:statement/Q64719818-F0364C6B-F319-424E-BBA0-77DBE52B20BF
p:P1476 wd:statement/Q64719818-AAC1C93F-EE90-4B29-97B9-681F51CB8788
p:P17 wd:statement/Q64719818-21BA50D1-789A-476F-A732-8784FB2C873F
p:P2899 wd:statement/Q64719818-9DD53828-5AD9-4B2B-914E-62A1F32B6664
p:P3098 wd:statement/Q64719818-347569A8-5E12-44E8-B58B-C128F5518FA5
p:P31 wd:statement/Q64719818-C6C49CDF-6214-47F9-960D-9C762A77C648
p:P4844 wd:statement/Q64719818-6EF3AD98-FA88-4C71-80F8-3D44994E51B9
p:P580 wd:statement/Q64719818-8C0D2660-DB31-469C-98B8-2D6D43C0CEE0
p:P582 wd:statement/Q64719818-2AC6783B-6035-419E-B3E2-235187894098
p:P6153 wd:statement/Q64719818-B6420E2F-248D-4E48-96A4-8A7A08463484
p:P8363 wd:statement/Q64719818-9240DD96-EA49-45D4-8F02-5FD1012B3E8F
p:P921 wd:statement/Q64719818-8F8B9D29-7F20-4724-AA31-83A79876DBE7
wd:statement/Q64719818-F1D72C75-1C95-4673-80DA-798A78A9A6DF
wd:statement/Q64719818-46053CA1-8BD3-40C4-95ED-AB5E56FC4F5A
wd:statement/Q64719818-EB25B1A2-80F7-41AC-B050-EFD36D7488CA
wdt:P1132 26.0^^xsd:decimal
wdt:P1476 "Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients"@en
wdt:P17 آمریقا متحده دولتلری
wdt:P2899 21.0^^xsd:decimal
wdt:P3098 "NCT00655226"
wdt:P31 සායනික අත්හදා බැලීම
wdt:P4844 interféron alpha
wdt:P580 "2008-03-01T00:00:00+00:00"^^xsd:dateTime
wdt:P582 "2010-05-01T00:00:00+00:00"^^xsd:dateTime
wdt:P6153 Mount Sinai School of Medicine
wdt:P8363 estudo intervencional
wdt:P921 depressieve stoornis niet anderszins omschreven
ഹെപ്പറ്റൈറ്റിസ്
هپاتیت سی
Pegilirani interferon alfa-2a
Download as: